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INTRODUCTION 
The  role  of  serum  complement  in  immune hemolytic reactions  has  been 
recognized for over sixty years (1). The manner of action and sequence of action 
of the several components of complement have been studied in a  variety of 
systems involving human or guinea pig complement, sheep erythrocytes, and 
rabbit  anti-sheep  erythrocyte antiserum  (2,  3).  However,  few  studies  have 
been  done  on hemolytic reactions  involving human antibody,  erythrocytes, 
and complement, or on immune hemolytic systems occurring in human dis- 
eases. 
Studies on the role of human complement in human disease states and in the 
hemolysis of human cells have been hampered by lack of a  convenient model 
system. The Donath-Landsteiner (D-L)  reaction is suitable for this purpose, 
as previously indicated (4),  because the antibody is an active hemolysin but a 
poor agglutinin and because the biphasic nature of the hemolytic reaction is 
readily susceptible  to  study of  early and late phases  of complement action 
separately. 
Recent studies have indicated that Cq, the first component of complement, 
initiates the action of human complement in complement fixation by antigen- 
antibody aggregates (5); that C'I is associated with esterase activity capable of 
hydrolyzing certain synthetic amino acid  esters  (6-8);  and that  there is  in 
serum a naturally occurring inhibitor of the esterase (9).  The current studies 
are all application to immune human hemolysis of the observations made on 
complement  fixation. They indicate  that  the  initial  cold phase  of  the  D-L 
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reaction can be completed using serum, partially purified C'I, or C'I  esterase, 
the  enzymatically  active  material  derived  from  Crl.  Further,  the  action  of 
Cq  esterase  can be blocked upon the addition of  the inhibitor purified from 
normal serum. 
MATERIAL  AND  METHODS 
Material and methods were similar to those described in the preceding paper (4). In addi- 
tion, the following are pertinent. 
Antlserum.--An  additional  antiserum  (complement-depleted antiserum  III)  was  kindly 
supplied by Drs. W.  S. Jordan, Jr. and J.  H. Dingle from their patient II  (10).  The native 
serum had been stored at  -20°C. since 1950. Purified antibody from case I  was diluted in 
barbital buffer so that it was concentrated 2.5 times with respect to original serum; during 
preparation, complement-depleted antisera from cases I, II, and III were diluted 1/1.5 with 
respect to original serum and were thereafter diluted appropriately in barbital buffer as noted 
in individual protocols. 
Fresh Normal Human Serum.--Human  serum was obtained as described in the previous 
paper (4). 
Fresh  Guinea  Pig Serum.--Fresh  guinea  pig serum was obtained by  cardiac puncture, 
separated from clotted blood, and stored at  --65°C. Several large pools of guinea pig serum 
which were obtained through the generosity of Dr.  E.  R. Arquilla had been adsorbed with 
sheep cell stroma and were free of hemolytic antibodies for human red cells. 
Preparation  of Complement Reagents.--R1,  lacking C'I, the soluble portion of serum follow- 
ing dialysis against pH 5.4 acetate buffer, ionic strength 0.02, at I°C. for 36 to 48 hours, was 
corrected to pH 7.4 -¢- 0.4  with 0.5 M NaOH, and adjusted to ionic  strength 0.15  with 1.0 
NaC1 in a final dilution of 1/1.5 with respect to original serum (11, 12). Cations were added 
to a concentration of 1.5 X  10  °4 M Ca  ++ and 5 X  10  -4 •  Mg  ++. The R1 was stored at -65°C. 
R2, lacking C'2, the insoluble portion of serum following dialysis against the above acetate 
buffer, was washed twice with the acetate buffer at 2°C.,  corrected to pH 7.4 -4:0.4  with 
0.5 ~  NaOH, adjusted to ionic strength 0.3 with 1.0 ~  NaCI, and stored frozen at --65°C. at 
a  final  volume of 0.75/1  with respect to original serum volume. At the time of use it was 
diluted with an equal volume of distilled water so that the final ionic strength was 0.15  and 
the final dilution was 1/1.5  (11, 12). Cations were added to a  concentration of Ca  ++,  1.5  X 
10  -4 M, and Mg  ++, 5 X  10  -4 g. The undiluted frozen material retained potency for at least 4 
weeks. 
R3, lacking C'3, was prepared from human serum by incubating selected normal sere with 
2 mg./ml, of zymosan (Fleischmann No.  711152) at 37°C.  for 60 minutes, followed  by cen- 
trifugation (3000 G for 30 minutes) at I°C. to remove the particulate zymosan (13). In guinea 
pig serum, 2 mg. zymosan/ml, failed to inactivate C'3, and 10 to 20 mg. caused inactivation 
of other components of complement. Therefore, R3 was made from guinea pig serum by first 
preparing a properdin-zymosan (PZ) complex (14), by incubating 1 ml. of human serum with 
2 rag.  of zymosan for 60 minutes at 17°C., washing the complex twice at 0°C.  with barbital 
buffer to remove occluded serum, and incubating the washed PZ complex with 1 ml. guinea 
pig serum at 37°C. for 1 hour. 
124, lacking C'4, was prepared from human and guinea pig serum by incubating 1 ml.  of 
serum with 0.25  volume of 0.15 M NH3 at 37°C.  for 60 minutes and thereafter neutralizing 
with 0.25 volume of 0.15 ~r HC1 (11). 
Human serum  heated at 51°C. for 30 minutes  lacked Ct2 but contained C'I,  C'3,  and  C~4. 
Human serum  heated at 56°C. for 30 minutes  contained significant amounts only of C'4. 
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performed by the double dilution technique using a  50 per cent hemolytic end-point  with 
amboceptor sensitized sheep cells (5,  12).  Total complement was measured according to a 
100 per cent hemolytic end-point, 1 unit being the least amount of serum capable of  causing 
complete hemolysis of a  standard number of sheep cells.  "Complement-equivalent" units in 
serum reagents deficient in one or more components of complement were based on the  total 
complement activity of the serum from which the reagents were prepared. 
Human serum reagents were considered satisfactory if they caused no hemolysis of sensitized 
sheep cells when used at the 4 unit level, but did cause complete or nearly complete hemolysis 
when used in combination with other of the inactivated reagents at the 1 unit level, and if 
they did not have anficomplementary properties.  Routinely only R1  -t-  R2 and R3  q-  R4 
recombinations were tested. 
Human R1, R3, and R4 could be prepared which met the above criteria, but human R2 
prepared in the usual manner often contained a small amount of C'2 (less then 5 to 10 units 
of an original 480 units) when measured by the dilution titration technique. As noted above, 
serum heated at 51°C.  for 30 minutes lacked C'2, but contained the other components. 
Satisfactory reagents from guinea pig serum could not be prepared in this fashion. Some 
preparations of guinea pig R1 were slightly hemolytic and did not recombine completely with 
guinea pig R2. R3 made with zymosan or human PZ was also slightly lyric; R4 was non-lytic 
and recombined satisfactorily with other reagents. Thus guinea pig reagents prepared in the 
prescribed fashion often failed to  meet the requirements established for human reagents and 
results of this part of the study were therefore subject  to these limitations in interpretation. 
Partially purified C'1 was prepared from pooled human serum, as previously described (6), 
and stored at  -20°C.  at pH 5.5,  ionic strength 0.30.  Under these conditions there was no 
activation to the esterase form. Immediately prior to use, pH was adjusted to 7.4 4- 0.4 with 
0.5 •  NaOH and ionic strength to 0.t5 by dilution with distilled water at 4°C. 
C'1 esterase, the enzymatically active form of C~I, which has no detectable hemolytic C'I 
activity but does possess esterase activity for certain synthetic amino acid esters, was pre- 
pared by incubation of partially purified C'I at pH 7.4 and ionic strength 0.15 for 15 minutes 
at  37°C  (6).  Esterase  activity of this preparation was  determined as  described previously 
(8,  15).  One unit is that amount of esterase which liberates 0.5 micromole of fitratable acid 
during incubation with N-acetyl-L-tyrosine ethyl ester for 15 minutes at 37°C. Approximately 
1 unit of esterase activity is generated from  100 to 200 units of partially purified C'I and 
corresponds to approximately 10 to 30 micrograms nitrogen. 
Dilutions of either Crl or C'I esterase were made in barbital buffer and used in the cold 
phase of the reaction in place of whole human serum. 
Esterase inhibitor  (EI)  was prepared from human serum by column chromatography as 
previously described (9,  16),  and stored at  -20°C.  One unit of inhibitor is defined as that 
amount which will inhibit the esterolytic activity of 10 units of C~I esterase under standard 
conditions (15) and corresponds to approximately 5 to 15 micrograms of nitrogen. Dilutions 
were  made in barbital buffer.  For studies in the  cold phase,  esterase inhibitor was either 
preincubated with C~I esterase or serum for 15 minutes at 1-4°C., or was introduced into the 
cold phase of the hemolytic reaction with C'I esterase, partially purified C'I, or serum just 
prior to addition of Donath-Landsteiner antibody and erythrocytes. The total volume of the 
reaction mixture was unchanged. To study the effect of inhibitor on cells after the cold phase, 
inhibitor was  incubated with the erythrocytes at  temperatures ranging from  1  °  to  42°C., 
usually in a total volume of 0.2 ml. of barbital buffer. Thereafter the cells were washed twice 
in barbital buffer at the same temperature and incubated in R1 at 37oC. 
The Donath-Landsteiner  reaction was performed as described in the previous paper with 
minor modifications  (4).  The initial reaction between cells,  antibody, and serum or serum 
reagents in a volume of 0.30 ml. at I°C. for 30 minutes is referred to as the ¢o/d phase.  There- 196  IMMUNE  HIYM.AN HEMOLYSIS.  II. 
after the cells were washed twice in barbital buffer at 2°C., and incubated in serum or serum 
reagents in a  volume of 0.3 ml. at 37°C.  for 30 minutes, referred to as the warm phase.  In 
all experiments the indicator reaction was hemolysis at 37°C.  On some occasions an additional 
reaction with esterase inhibitor was interposed between the cold and warm phases as described 
above. In most experiments, serum and serum reagents were  diluted  1/1.5  with respect  to 
original serum, and therefore 0.15 ml. was used instead of the 0.1 previously described. When 
a combination of reagents was used, 0.15 ml. of each was used in the reaction mixture. 
The level of antibody and type of erythrocyte  (PNH or normal)  were selected so that 
hemolysis occurred only when fresh serum was present in both the cold phase and the warm 
phase of the reaction. In each instance the only source of any component of complement was 
the fresh serum or serum reagent, for none of the components of complement was present in 
measurable quantity in the purified antibody fraction or in the complement-depleted antisera. 
Based on the studies reported in the companion paper, it was possible to  make  observations 
on the following combinations of antibody and erythrocytes: complement-depleted antiserum 
I and normal red cells; complement-depleted antiserum II and normal cells; purified antibody 
I and PNH cells.  Details of individual experiments are described separately below. 
Similar to observations reported in the previous paper, these three combinations of eryth- 
rocytes and antibodies exhibited different degrees of sensitivity with respect to amounts of 
complement required for hemolysis. In the most sensitive reaction using PNH erythrocytes 
and purified antibody from case I  there was at least a  5-fold excess of complement in both 
the cold and the warm phases. In the least sensitive reaction involving normal cells and com- 
plement-depleted antiserum I, the amount of complement was limiting, and dilution of serum, 
especially in the warm phase, resulted in decreased hemolysis. The reaction involving normal 
cells and the more potent complement-depleted antiserum II was intermediate in sensitivity. 
These differences may account for some of the minor inconsistencies noted in the following 
experiments, particularly in experiments involving recombination of reagents deficient in one 
or more components of complement. 
RESULTS 
I.  Requirement  for the Components of Human Complement 
The requirement for the individual components  of complement in the total 
reaction was determined by using the various serum reagents lacking one com- 
ponent of complement  in both  the cold and warm phases;  requirement for 
specific components in the cold phase was tested using various serum reagents 
in the cold phase and whole serum  in the warm; and similarly,  component 
requirements in the warm phase were tested using serum in the cold and various 
reagents in the warm. 
Expe~4mental.--In  sequence the following were mixed and incubated at  1°C.  for  30  min- 
utes: 
(a)  0.05 ml. of 25 per cent suspension of normal or PNH erythrocytes; 
(b)  0.15 ml. of serum or serum reagent diluted 1/1.5; 
(c)  0.05 ml. of purified antibody I, or 0.1  ml. undiluted complement-depleted antiserum 
I, or 0.1 ml. of complement-depleted antiserum II, diluted 1/4; 
(d)  barbital buffer to adjust the final volume to 0.30 ml. 
Following the cold phase, the cells were washed twice in 3 ml. barbital buffer at 2°C.; 0.15 
ml. of serum or serum reagent was added; the volume was corrected to 0.3 ml. with barbital 
buffer; and  the  mixture was incubated at  37°C.  for 30 minutes.  Following centrlfugafion, C. F. HINZ~  JR., M. E. PICKEN,  AND  I. H. LEPOW  197 
hemolysis was scored visually from 0 to +++.  Under these experimental conditions a score 
of +++  corresponded to approximately 50 per cent hemolysis. 
A.  Total  Reacgon.--There  was  a  requirement  for  all  four  components  of 
complement  at  some  time  during  the  hemolytic  reaction  (Table  I).  When 
incubation  took place  in a  reagent  in which  any component of complement 
was lacking in both the cold and warm phases, no hemolysis occurred in any 
of the  three  reaction  systems  tested.  An apparent  discrepancy, hemolysis in 
TABLE I 
Requirement  for the Components  of Complement  in both Phases of the Donath-Landsteiner Reaction 
Hemolysis in various reaction systems 
Erythrocytes  PNH*  Normal  Normal 





51  ° serum 
R3 
R4 
56  ° serum 
R1 +R2 




























The same reagents were used in both the cold and the warm phase of the reaction. 
Hemolysis was scored visually from 0  to +++;  +  corresponded  to approximately  5 
to 10 per cent hemolysis; ++,  10 to 20 per cent hemolysis; and +++,  20 to 50 per cent 
hemolysis. Higher  levels of hemolysis were not attainable  under these  experimental  con- 
ditions. 
* Paroxysmal nocturnal hemoglobinuria. 
R2, was noted with the sensitive  PNH erythrocytes and purified antibody I. 
This could be explained on the basis of the presence of small amounts of C'2 
in the R2,  sufficient to cause hemolysis of this,  the most sensitive of the sys- 
tems.  When  serum  heated  to  S1 °,  lacking  measurable  C'2,  was  utilized,  no 
hemolysis occurred. 
Recombination  of  reagents  resulted  in  restoration  of hemolysis  in  two  of 
the reaction  systems,  but  failed to occur in the least  sensitive  reaction,  that 
involving normal erythrocytes and the less potent complement-depleted anti- 
serum I. The decrease in total complement activity in recombinations of serum 
reagents (17) was sufficient to account for the lack of hemolysis in this reaction 
system,  which  permitted  little  dilution  of  serum,  particularly  in  the  warm 
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B.  Cold  Phase.--To  test  the  requirement  for  specific  components  in  the 
cold,  various  serum  reagents  were  used  in  the  cold  phase  and  whole  serum 
was used in  the  warm. Hemolysis failed to occur only when  C'I was absent 
in the cold (Table II). Thus, R1, or 56 ° serum, did not complete the cold phase 
successfully even though  Cq  was present during the subsequent warm phase. 
Reagents lacking  C~2, Cr3,  or Ct4,  but  containing  C'I were fully active. Re- 
combination of R1  with R2 resulted in a  fully active system. 
Therefore C~I was the only component of complement required to complete 
the cold phase. If it was not present during the cold phase hemolysis failed to 
occur even when C~I was present in the warm phase as whole serum. 
TABLE II 
Requirement  for the Components of Complement in the Cold Phase of the 
Dona !h-Landsteiner Reaction 
Hemolyis in various reaction systems 
Erythrocyte  PNH  Normal  Normal 





51 ° serum 
R3 
R4 
56  ° serum 
R1 +  R2 



























Various serum reagents were used in the  cold phase. After the  cells were washed, the 
reaction was completed in the warm phase in whole serum. 
C.  Warm Phase.--When whole serum was used in the cold phase and various 
serum reagents in the warm phase,  evidence for a  requirement for C'2,  C'3, 
and  C'4 in  the  warm phase was  obtained  (Table III). In all these  reaction 
systems some hemolysis occurred in R1, when serum had provided C'I during 
the prior cold phase, although this was much more marked with the sensitive 
PNH  erythrocytes  than  with  normal  cells. 
When C'2 was lacking in the warm phase, no hemolysis occurred. Again the 
apparent discrepancy with the more sensitive PNH erythrocytes was probably 
due to small amounts of C'2 which  were present in R2 preparations, for 51 ° 
serum,  lacking  only C'2,  was  inactive. 
R3 was inactive in all reactions, indicating that C'3 is essential in the warm 
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A  requirement for C'4 in the warm phase was apparent in both reactions 
involving  normal  cells.  With  the  sensitive  PNH  erythrocytes,  hemolysis 
occurred in R4 when serum had been used in the prior cold phase, indicating 
that some C~4 had interacted during the cold phase and suggesting that C~4 
might participate in either the cold or warm phase. This was supported by the 
observation that when R4,  containing Ctl  but lacking Ct4, was used in the 
initial cold phase, hemolysis failed to occur in R4 in the warm, but did occur 
in whole serum. Observations reported below indicate that C~I and Ct4 may 
TABLE  III 
Requirement for the Components of Complement in the Warm Phase of the 
Donath-Landsteiner Reavtion 
Hemolysis ha various  reaction systems 
Erytbrocyte  PNH  Normal  Normal 





51  ° serum 
R3 
R4 
56  ° serum 
R1 +R2 

























The  reaction in  the cold phase was performed with whole serum.  The various serum 
reagents were then used in place of whole serum in the warm phase. 
interact at low temperatures, whereas Ct2 and Cr3 react only at higher tem- 
peratures. 
Recombination of reagents showed restoration of hemolytic activity relative 
to the sensitivity of the reaction system to complement, as previously noted. 
D. Recombination  of  Specifically  Inactivated  Serum  Reagents.--A  more 
detailed study of the recombination of the variously inactivated reagents in 
both phases of the reaction using PNH erythrocytes and purified antibody I 
demonstrated  reactivation  on  recombination,  indicating  that  the  lack  of 
hemolytic activity of the various reagents was due to a deficiency of the vari- 
ous components and not to the development of inhibitory properties  in the 
reagents (Table IV). Restoration on recombination was not regularly achieved 
using the less sensitive normal ceils, probably related to (a) the partial loss of 
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reagents  (11),  and  (b)  to the greater  requirement  for complement,  especially 
in the warm phase,  in those reactions utilizing normal cells. 
E.  Studies  on  Guinea  Pig  Complement.--In  studies  on  the  Donath-Landsteiner 
reaction using guinea pig complement, Jordan, Dingle, and Pillemer reported in 1951 
that Ct4 was the only component of complement required in the cold phase, and C~2 
the only component required  in  the warm phase  (10).  Because  the current  results 
with human complement were inconsistent with this report, studies were attempted 
utilizing guinea pig serum as the source of complement and antisera from patients I 
TABLE IV 
Recombination of Serum-Reagents in the Donath-Landsteiner Reaction 






50  ° serum 
R1 +  R2 
R1 +  R3 
R1 +  R4 
R2 +  R3 
R2 +  R4 
R3 +  R4 
50  ° serum +  R1 
50  °  "  +  R3 
















Reagents or combinations were used in both the cold and warm phases of the reaction 
utilizing PNH cells and purified antibody I. 
and II as well as the antiserum used by Jordan, Dingle, and Pillemer. These studies 
were sharply limited by two factors: first, guinea pig serum contained hemolytic anti- 
bodies active against human cells, particularly aginst PNH erythrocytes which have 
extreme  susceptibility  to  hemolytic antibdies;  and,  second,  there  was difficulty  in 
preparing guinea pig reagents  in which there was complete inactivation  of specific 
components and yet adequate activity when they were recombined. The first problem 
was met by utilizing guinea pig serum which had been adsorbed with sheep cell stroma, 
resulting in removal of the antibodies for human erythrocytes with only moderate loss 
of complement activity. 
Within the limits imposed by the second problem, that of preparing adequate 
reagents, the requirements for specific components with guinea pig serum were 
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ExperimentaL--Procedures  were similar to those used in studies of human serum, modified 
slightly to reproduce the conditions described by Jordan et al.  (10). The guinea pig sera were 
free of agglutinins for human cells and contained approximately one-half the original com- 
plement. 
Antiserum levels and  cells  used were:  0.05  ml.  complement-depleted antiserum I  and 
PNH cells; 0.10 ml. complement-depleted antiserum I and normal cells; 0.10 ml. complement- 
depleted antiserum II, diluted 1/8, and normal cells; and 0.10 ml. complement-depleted anti- 
serum IH and normal cells. 
The hemolytic reaction was performed by mixing in sequence 0.25  ml. of a  5 per cent 
suspension of erythrocytes, 0.1 ml. of serum or serum reagents, and antibody, and incubating 
TABLE V 
Requirement for the Components  of Guinea Pig Complement  in the 
Donath-Landsteiner  Reaction 
Reagent in  Reagent cold  Serum cold 
Serum reagent  cold and warm  serum warm  reagent warm 
Guinea pig serum (without antiserum) 
Guinea pig serum 
"  "  R1 
"  "  R2 
"  "  R3 
"  "  R4 
"  "  56  ° Serum 
"  "  R1 +  R2 
"  "  R3 +  R4 
0 
+++  +++ 
0  0 
0  ++ 
0  +++ 
0  +++ 
0  0 
tr  ++ 









The data depicted were from an experiment utilizing PNI-I erythrocytes and complement- 
depleted antiserum I. When a reagent was used in one phase of the reaction, whole serum was 
used in the alternate phase. 
the mixture at I°C. for 30 minutes. Thereafter the cells were washed  twice in 3 ml. barbital 
buffer at 2°C. and incubated at 37°C. for 30 minutes with 0.1 ml. of serum or serum reagent 
in a total volume of 0.3 ml. in barbital buffer. 
The specific differences from the method used by Jordan, Dingle, and Pillemer were that 
guinea pig serum was fresh frozen instead of lyophilized,  and had been adsorbed with human 
erythrocytes; and that the antisera were treated with zymosan and ammonia prior to heating 
to insure total inactivation of all components of complement. 
All  the  reaction  systems  tested  showed  requirements  similar  to  those  re- 
ported above for human serum (Table V). First, none of the reagents deficient 
in any component of  complement resulted  in hemolysis when it was  used in 
both phases of the reaction, indicating that all four components were required. 
Second, R1 or serum heated to 56°C. for 30 minutes failed to complete success- 
fully the initial cold phase, whereas R2, R3, and R4 were active; thus, reagents 
lacking C'I were inactive, whereas reagents deficient in or lacking other com- 
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hemolytic in the warm phase; R2 and R3 were not; and R4 was hemolytic on 
some occasions, indicating that C~4 reacted in either the cold or warm phase. 
Summary.--These  data  on human  and  guinea pig serum  complement are 
interpreted as indicating that  C'I  is a  requirement for the cold phase, is the 
only component so  required,  and  therefore initiates  the  hemolytic process; 
that C~4 may interact during the cold or warm phase; and that C~2 and C~3 
are required and must interact during the warm reaction. These observations 
emphasize  the  requirement  for  all  components  of  complement  and  clearly 
eliminate C'4 as the sole requirement in the cold phase and  C~2  as the sole 
requirement in the warm phase (10). 
II.  Partially Purified C~1 and C'1 Esterase as a Source of 
Complement in the Cold Phase, and Inhibition  of 
Hemolysis by Serum Inhibitor of C~1 Esterase 
A.  Partially Purified C~1 and C~1 Esterase.--A partially purified fraction of 
C~I has been isolated from serum free of the other components of complement 
(6). At pH 7.4,  ionic strength 0.15,  and 37°C.  this preparation rapidly loses 
hemolytic Cq activity and acquires enzymatic properties capable of hydrolyz- 
ing certain synthetic amino  acid esters and interacting with  C~4 and Ct2 in 
serum (6, 8).  It is heat labile and its esterolytic and complement-interacting 
properties are blocked by an inhibitor present in fresh serum. If C~I is the only 
component required in the cold phase of the Donath-Landsteiner reaction, as 
the  previous observations  indicate,  then it  should  be  possible  to  substitute 
purified C~I for whole serum in the cold phase of the reaction. Further, if the 
esterase  properties  are  responsible  for  the  functional  role  of  Crl,  then  the 
preparations with active esterase properties and no demonstrable C~I activity 
should also complete the cold phase successfully. Experiments were designed 
to test these hypotheses. 
ExperimentaL--The reaction mixtures for the cold phase were similar to those previously 
described, except that partially purified C'I or Ctl esterase was substituted for whole human 
serum in some tubes in amounts indicated in Table VI. Mixtures contained 0.05 ml. 25 per 
cent PNH cells, 0.05 ml. purified antibody I, and 0.1 ml. of serum, Cq or Ctl esterase as 
indicated, in a total volume  of 0.3 ml. The warm phase was performed  as previously  described 
using 0.10 ml. of undiluted serum or 0.15 ml. of serum reagents. 
Antibody, partially purified C~I,  or Cq  esterase had no effect in the  cold 
phase individually, but either the Ctl or the C~I esterase in conjunction with 
antibody completed the cold phase successfully so that hemolysis occurred sub- 
sequently in the warm phase in either serum or R1 (Table VI). Various amounts 
of  esterase  were  required  to  complete  the  cold  phase  depending  upon  the 
potency of the antibody and sensitivity of the cells. As little as 0.05 unit of C'I 
esterase, corresponding to approximately 5 to  10 units of C'I  and 0.5  to  1.5 
micrograms nitrogen, was  required in the reaction mixture when PNH  cells C.  F.  HINZ,  JR.,  M.  E.  PICKEN,  AND  I.  H.  LEPOW  203 
and the potent antiserum II were used; as much as 4 units were required with 
normal  cells and  the  less potent  purified antibody I.  Increasing amounts  of 
esterase caused progressively greater amounts of hemolysis (Fig. 1). 
When Cq esterase was the source of complement in the cold phase, C~2, Ct3, 
and C'4 were required for hemolysis in the warm, but C~I was not. When the 
preparations of Cq  esterase were inactivated by heating at 56°C.  for 30 min- 
utes, they were no longer effective in completing the cold phase (Table VI). 
TABLE VI 
Partially  Purified  C'1  and  C'I  Esterase  in the  Cold Phase  of the Donath-Landsteiner  Reaction 
Antibody  Source of complement 
Hemolysis 
Purified  Cold phase  Warm phase  antibody  I 
0.05 ml. 
0.05 ml. 
0.05  " 
0.05  " 
0.05  " 
0.05  " 
0.05  " 
0.05  " 
0.05  " 
0.05  " 
Partially purified  Cq  (equivalent  to  0.9 
unit C'I esterase) 
0.9 unit C'1 esterase 
serum 
Partially purified  C'1  (equivalent  to  0.9 
Serum 
unit C'I esterase) 
0.9 unit Cq esterase 
0.9  "  "  " 
0.9  "  "  " 
0.9  "  "  " 
0.9  "  "  " 
0.9  "  "  " 
0.9 unit Cq esterase heated to 56°C. 
R1 
R2 














Serum  -- fresh human serum. 
The kinetic characteristics of the cold phase of the reaction were the same 
whether  serum or C'I  esterase was used as the source of complement  (Table 
VII).  In both  instances,  the reaction proceeded best at  I°C.  and  was nearly 
complete in 30 minutes. It had an apparent pH optimum between pH 7 and 8, 
and was inhibited by increases in ionic strength. Similarly, the cold phase of the 
reaction was blocked by addition of 3  X  10  -8 M NaaEDTA or Na~MgEDTA to 
the system, but it was not blocked by Na~CaEDTA, indicating that Ca  -H" was 
required. The rates of hemolysis in the warm phase were similar whether whole 
serum or Cq  esterase was used in the cold (Fig. 2). 
B.  Other sources of Esterase Activity.--Eluates  of antigen-antibody aggregates pre- 
viously "activated" by exposure to human serum have also been observed to have 
properties similar to Cq esterase (7). They are capable of hydrolyzing the same syn- 
thetic amino acid esters and interacting with C'4, are heat labile, and blocked by the 204  IMMUNE  HUMAN  HEMOLYSIS.  II. 
serum inhibitor of Ctl esterase. Preparations of this "active eluate" were also effective 
in completing the cold phase of the Donath-Landsteiner reaction in place of serum 
or Cq  esterase.  Although detailed studies were not performed,  in the D-L reaction 
the preparations of "active eluate" had less than one-half the activity of Cq esterase 
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FIG. 1.  Quantitative effect  of C~I esterase  in the cold  phase of  the Donath-Landsteiner 
reaction. The reaction mixture contained  PNI-I erythrocytes, 0.05 ml. purified  antibody I, 
and Cq esterase,  in a volume of 0.3 ml. Warm phase contained 0.3 ml. R1. 
TABLE VII 












Inhibited >  0.30 





Inhibited -> 0.40 
Ca~- 
For the studies using C'1 esterase,  PNH erythrocytes, 0.05  m]. of purified antibody I, 
and 0.5 unit CJ1 esterase were used in the cold phase, and 0.3 ml. of R1 in the warm phase. 
For studies with serum in the cold, PNH erythrocytes, 0.05 ml. of purified antibody I, and 
0.1 ml. serum were used in the cold phase, and 0.1 ml, undiluted serum in a total volume of 
0.3 ml. in the warm phase. 
preparations  relative  to  their  esterolytic  activity  as  determined  by  the  standard 
assay (15). 
The residual material from ethanol Fraction II +  III of antiserum I, after separa- 
tion of the gamma-2 globulin fraction which was used as purified antibody I, was not 
only observed  to  contain some residual antibody activity, as reported  by Deutsch 
and coworkers (19), but also contained 25 units per ml. of esterase activity at original C. F. HINZ~  JR.~ M.  E. PICKEN~  AND  I. H. LEPOW  205 
serum concentration.  It was therefore  of interest  to determine  whether this fraction 
of serum  containing  both antibody and C'1 esterase  was capable of completing  the 
cold phase of the D-L reaction in the absence of other sources of complement or anti- 
body. 
At the level of 0.05 ml. the fraction was active alone in completing the cold phase 
of the D-L reaction. It was inactivated by heating at 56°C. for 30 minutes, a procedure 
which inactivates  esterase  properties  but not antibody. The activity of the heated 
fraction could accordingly be restored by addition of fresh normal serum. The activity 
of the unheated fraction was also blocked by an inhibitor of C'I esterase derived from 
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FIG. 2.  Relative rates of hemolysis in the warm phase using C'l esterase or serum in the 
cold phase. Reaction mixtures included normal erythrocytes with 0.1  ml. of complement- 
depleted antiserum II, or PNIt cells and 0.05 ml. purified antibody I. Source of complement 
in cold phase was 0.1 ml. of serum or 1.0 unit of C'I esterase. In the warm phase 0.1 ml. of 
serum was used in a total volume of 0.3 ml. 
C. Inhibition of the Donatk-Landsteiner  Reaction by Partially Purified Serum 
Inhibitor  of C'1  Esterase.--The  foregoing data  strongly suggested  that  C'I 
esterase was responsible for the first stage of the hemolytic action of human 
complement in  the  Donath-Landsteiner reaction.  Additional supporting evi- 
dence was obtained from studies on inhibition of the hemolytic reaction. Re- 
cently Pensky and Levy (9)  have obtained  in partially purified form an in- 
hibitor of C'I esterase previously demonstrated to be present in normal human 
serum. The inhibitory property is completely inactivated at 60°C. for 30 min- 
utes and is contained in an alpha-2 globulin fraction of serum which has been 
purified 100- to 200-fold. It blocks stoichiometrically the esterolytic and comple- 
ment-interacting properties of C'I esterase (15).  One unit of esterase inhibitor 
(EI) is designated as that amount capable of inactivating 10 units of C'I esterase 
under standard conditions. This material is also capable of blocking the Donath- 
Landsteiner reaction. 206  IMMUNE  HUMAN HEMOLYSIS.  II. 
1.  Cold phase: 
ExperimentaL--Just prior to performance of the cold phase, esterase inhibitor was mixed 
with equivalent amounts of Cq esterase, partially purified Cq, or human serum at 4°C. in an 
ice bath; 0.05 ml. PNH erythrocytes, 0.05 m]. purified antibody I, and barbital buffer were 
then added to a total volume of 0.30 ml. and the mixtures incubated for 30 minutes at  I°C. 
The cells were washed twice in 3 ml.  of barbital buffer at 2°C. and incubated at 37°C.  with 
0.3 ml. R1. 
In the absence of inhibitor, equivalent amounts of CI1 esterase, partially puri- 
fied Cq, or whole serum caused equivalent hemolysis (Table VIII). Addition of 
twice the stoichiometric concentration of esterase inhibitor to Cq esterase just 
prior to the cold phase prevented hemolysis, but the same amount of inhibitor 
had  no  effect on the  reaction  when  serum  or partially purified  C~1  was  the 
source of complement in the cold phase. 
TABLE VIII 
Effect of Esterase Inhibitor  on the Cold Phase of Donath-Landsteiner Reaction 
Reagent in cold phase 
0.9 unit Cq esterase 
Partially purified Crl (equivalent to 0.9 unit C'I esterase) 
Serum (containing 90 to 120 units Cq) 
Hemolysis 
_ .With inhibitor  No inhibitor  (0.18 unit) 
+++  tr 
+++  +++ 
+++  +++ 
To avoid the possibility that the lack of effect of inhibitor on whole serum in 
the cold phase was due to excess of serum a  constant amount of inhibitor was 
used with serum serially diluted to a  point where it no longer had hemolytic 
activity. At no dilution of serum did inhibitor affect the cold phase activity of 
the serum. The quantitative effect of inhibitor on Cq  esterase was similar to 
that demonstrated in the esterase assay, approximately 0.10 unit of inhibitor 
blocking 1.0 unit of esterase (Fig. 3). 
Prior incubation of cells with inhibitor had no effect if the cells were washed 
before introduction into the cold phase. 
The data were interpreted  to indicate  that  the  inhibitor  blocked the par- 
ticipation of the free enzyme in the cold phase, but was without effect when ac- 
tivation of Ctl to the enzymatic form evolved from serum or partially purified 
C'I at the erythrocyte surface. This is consistent with observations described 
above indicating  that  the  cold  phase  is  completed  successfully when  whole 
serum,  R3,  or R4,  all of which  contain  inhibitor,  is used in  the  cold phase. 
The  data  offer further  evidence  that  enzymatic activity  is  involved  in  the 
hemolytic effect of Cq. C.  F.  HINZ,  JR.,  ~[.  E.  PICKEN~ AND  I.  H.  LEPOW  207 
2.  Effect of inhibitor on cells after completion of cold phase: 
The esterase inhibitor also blocked the hemolytic reaction when it was in- 
cubated with cells after they had been "activated" by exposure to antibody 
and a source of C'I in the cold phase. 
Experime~al.--Mter completion of  the usual  cold  phase  (utilizing  PNH  erythrocytes, 
0.05 ml. of purified antibody I, and 1.0 unit C'I esterase, or equivalent amounts of serum or 
partially purified C'I), the cell complexes, referred to as "activated" cells, were washed twice 
in 3 ml. barbital buffer at 2°C.  These were incubated with various amounts of esterase in- 
hibitor, usually 0.1 unit, under various conditions of time, temperature, pH, and ionic strength, 
in a total volume of 0.2 ml. The cells were again washed twice in 3 ml. barbital buffer at room 
temperature, and finally incubated in 0.3 ml. R1 at 37°C. for 30 minutes. In each experiment, 
cells labeled "control" in the figures were incubated in barbital buffer in place of inhibitor 
under similar conditions. Adjustments of temperature, pH, and ionic strength were performed 
as previously described. 
0.15 
0  Unit C'  Esterase 





0  !  I  I  I  I 
0  0.02  0.04  0.06  0.08  0.10 
UNITS of INHIBITOR 
FIe. 3.  Quantitative effect of esterase inhibitor on C'I  esterase in the cold phase of  the 
I)onath-Landsteiner reaction. 
The effect of esterase inhibitor on "activated"  cells under these conditions 
was  time,  temperature and  concentration dependent.  When  cells  which  had 
been exposed in the cold phase to 1.0 unit of esterase were subsequently exposed 
to 0.10 unit of inhibitor, there was no effect at  I°C.  in 30 minutes and only 
slight effect after 20 hours. At higher temperatures the inhibitor rendered cells 
progressively less susceptible to hemolysis, complete inactivation taking place 
in 60 minutes at 32°C.  (Figs. 4, 5). A larger amount of inhibitor resulted in 
more rapid inhibitory effect (Fig. 6). Under similar conditions cells incubated 
with buffer in place of inhibitor underwent little or no decrease in sensitivity to 
subsequent hemolysis in R1. No conclusions can be  drawn regarding stoichio- 
metric relationships, because there are no data on the quantity of C'I esterase 
which actually reacted with erythrocytes during the cold phase. 208  IMMUNE HUMAN HEMOLYSIS. II. 
This  effect of inhibitor on  "activated"  cells was  the same whether  C'I  es- 
terase, partially purified C'1, or serum was used in the cold phase, in contrast 
to the observations in the cold phase, in which only C'l esterase was affected. 
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FIO. 4.  Interaction of "activated" cells with esterase inhibitor in the Donath-Landsteiner 
reaction: effect of temperature. 
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Fro. 5.  Interaction of "activated" cells with esterase inhibitor in the Donath-Landsteiner 
reaction: effect of time of incubation. 
D.  Elution  of Esterase Activity from Erythrocytes.--Becker  has demonstrated 
that CI1  esterase activity can be eluted from sensitized sheep cells after they 
have been exposed to guinea pig serum at 0°C.  (20). Similar observations have 
been  made  in  the  Donath-Landsteiner  system  by increasing the  amount  of 
antibody, and  using an  excess of whole human  serum  during the initial cold 
phase. C.  ~'.  Y~.NZ, ]R.~ M.  E.  PICKEN, AND I.  It.  LEPOW  209 
/~xperimenCd.--Replicate  samples of 0.05 ml. of a 25 per cent suspension of PNtt erythro- 
cytes, 0.10 mL of human serum, and 0.20 mL of purified antibody I were incubated at 1°C. 
for 30 minutes and the ceils washed twice with barbital buffer. To each tube 0.2 ml. of 5 × 
10  .-8 M  NaaEDTA in barbital buffer without divalent cations was added and the cells  incubated 
at 1~C. for 15 minutes. After centrifugation the superuatants from all tubes were pooled, and 
CaCI~ was added to a fial concentration of 5 X  10  -8 g. Similar reaction  mixtures lacking 
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FIG. 6.  Interaction of "activated" cells with esterase inhibitor in the Donath-Landsteiner 
reaction: effect of concentration of inhibitor. 
The eluate was tested for C'1 esterase activity in the standard  assay (15). It was tested 
for activity in the cold phase of the D-L reaction in the usual manner, utilizing PNH erythro- 
cytes and purified antibody I. It was also tested for antibody activity in the D-L reaction by 
using it in the cold phase in conjunction with PNI-I erythrocytes and fresh serum. The ability 
to inactivate C'4 was determined by incubating 0.05 ml. of eluate with 0.05 ml. of heated 
serum (56°C., 30 minutes) or R1 for 30 minutes at 1°C., and then measuring the C'4 activity 
of the resulting mixture with R4. 
The eluate from "activated" cells contained (Table IX): (a) esterase activity 
capable of hydrolyzing acetyl-T.-tyrosine ethyl ester in the usual assay for es- 
terase; (b) activity which could be substituted for C'I esterase in the cold phase 
of the Donath-Landsteiner reaction, but no antibody activity; and (c) activity 
capable of inactivating C'4 in heated serum or R1. Thus, the eluate from "ac- 
tivated" erythrocytes had similar properties to C'I esterase.  The eluate from 
cells incubated in the  initial cold phase  with serum alone or antibody alone 
did not possess these activities. 
It is to be emphasized that the amount of activity recovered was small rela- 
tive to the amount of potential C'I esterase activity present in the volume of 
serum initially used. Particularly in the esterase assay, the amounts of activity 210  IMMUNE  HUMAN ItE~OLYSIS.  II. 
detected were near the lower limits of sensitivity of the assay procedure.  None- 
theless,  activity  by  all  three  parameters  was  detectable  in  the  eluate  from 
"activated"  cells and was not detectable in the controls. 
Summary.--Partially purified C'I or the activated enzyme, CI1 esterase, suc- 
cessfully completed the cold phase  of the hemolytic reaction in the absence of 
the other components  of complement.  Serum inhibitor of C'I esterase blocked 
the  effect  of  Cq  esterase  in  the  cold  phase  of  the  reaction,  and  diminished 
hemolysis  when  exposed  to  "activated"  cells after  the  completion of  the  cold 
TABLE IX 
Properties Eluted  from Erythrocytes after the Initial Cold Phase 
Reactants in cold phase 
Antibody-erythrocyte-normal serum 
Antibody-erythrocyte- -- 
--  -erythroeyte-normal serum 













phase.  Esterase activity was eluted from erythrocytes following the cold phase 
when whole serum was the source of complement in the cold. 
III. The Sequential Interaction  of the Components of Complement and 
Requirement for Divalent Cations in Separate Steps 
Experiments were designed to determine the order in which the several com- 
ponents  of complement  interacted  in the Donath-Landsteiner  reaction. 
ExperimentaL--Two to four successive  reactions were performed as follows. The cells were 
washed twice with 3 ml. of barbital buffer at 2~C. between each step. 
Reaction I. 0.05 ml. of a 25 per cent suspension  of PNH cells, 0.08 ml. of purified antibody 
I, and  1.5 units of Cq esterase, in a  total volume of 0,3  ml. were incubated at  I°C. for 30 
minutes in the usual cold phase.  Mter washing,  the cells were incubated in the intermediate 
reactions, or were incubated directly in reaction IV in R1 at 37°C. 
Reaction II. Cells from reaction I  were incubated with 0.1  ml. of heated serum  (56°C., 
30 minutes) and 0.1 ml. barbital buffer at I°C. for 30 minutes. C~4 was the only measurable 
component of complement in the heated serum. 
Reaction III. Mter washing,  cells from reaction II were incubated at 25°C. for 30 minutes 
with 0.1 ml. R3 or equivalent amounts of other serum reagents, as noted in the tables, and 
0.1 ml. barbital buffer. 
Reaction IV. Mter washing,  cells from one of the previous reactions were incubated  in 
0.1  ml. of serum, or the equivalent of R1  or other serum reagent at 37°C.  for 30 minutes. 
R4, which had been heated to 51°C. for 30 minutes, contained C'3, but lacked C'4 and C'2. 
When the various salts of EDTA were introduced, barbital buffer without added divalent 
cations was used as diluent. EDTA was made up in 0.15 ~  NaCI and used in a final concen- 
tration of 3 X  10  .3 5. The volumes of reaction mixtures were unchanged. C.  F.  HINZ,  JR.,  M.  E.  PICKEN,  AND  I.  H.  LEPOW  211 
Utilizing C'I esterase in the initial step of the reaction, it was possible to in- 
teract the cells sequentially with the four components of complement to demon- 
strate  that the interaction occurred in the order C'I, C'4,  C'2, C'3 (Table X). 
As previously noted, partially purified  C'I  or C'I esterase lacked the other com- 
ponents  of complement.  It interacted  optimally at  I°C. in the presence of cells and 
antibody  (reaction I), rendering those cells susceptible to lysis in R1 or serum  (reac- 
TABLE X 
Sequential  Interaction of Components of Complement in the Donatk-Landsteiner Reaction 
Reaction 
Hemolysis 
I  II  III  IV 




ct  ¢1 
56 ° serum 
C'l-esterase 
~  cc 
1"6".; 30 rain. 
56  ° serum 
56o  ,, 
C'lesterase 
R4 
56  ° serum 
56  °  ,, 
Buffer 
R4 
56  ° serum 
56  °  ,, 
56  °  ,, 
56  °  ,, 








R3 (25 ° C.) 
51 ° (25°C.) 
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A dashed line indicates that the reaction step was omitted. 
R4--51  ° serum refers to R4 which was subsequently heated to 51 ° for 30 minutes. 51 ° serum 
and 56  ° serum were heated at the appropriate temperature for 30 minutes. 
The temperature at which reaction III took place is indicated in parentheses. 
tion IV).  C'1 was the only component required during this initial stage at  1°C. The 
initial reaction required Ca  ++, as indicated by the fact that it was blocked by 3  ×  10  -3 
Na3EDTA and Na~MgEDTA, but not by Na~CaEDTA  (Table XI). 
Following exposure  to  C'1  or  C'1  esterase  the  cells were  incubated  at  1°C.  for 
30 minutes  in serum heated  to  56°C.  (reaction II, Table X).  This  serum contained 
considerable C'4 activity, no detectable C'3 activity, and no C'1 or C'2. Thereafter, 
the cells could be hemolyzed in R4 in reaction IV, indicating that C'4 had interacted 
during exposure to the 56°C.  serum. The 56°C.  serum could not be reacted success- 
fully before C'1 esterase.  When  C'4 was lacking during reaction II, hemolysis failed 
to occur subsequently if C'4 were excluded from the subsequent steps. After reaction 212  IMMUNE  HUMAN  HEMOLYSIS.  II. 
with C'4, both C'2 and C'3 were required for hemolysis, since subsequent exposure to 
R3  or  R4  heated  to  51°C.  failed  to  cause lysis.  Ct2  could  not be interacted before 
C'4, as evidenced by the fact that hemolysis failed to occur if the cells were exposed 
to reagent lacking C'4 but containing C'2  (R4) and then to one lacking C'2 but con- 
TABLE  XI 
The Effect of Various Salts of EDTA  on the Several Stages of the Action 




I  II  III  IV 
25"C.; 30 rain.  37°C.; 30 rain.  1"C.; 30 rain. 
C'I esterase 
Cq esterase + 
Na~EDTA 
C'1 esterase q- 
NasMgEDTA 
Cq  esterase q- 
Na2CaEDTA 
Cq esterase 
1°C.; 30 rain. 
56  ° serum 
56  ° serum  -b 
NaaEDTA 
56  ° serum  q- 
Na2MgEDTA 
56  ° serum  -q- 
NasCaEDTA 
56  ° serum 
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The various salts of EDTA were used at a concentration of 3  X  10  -3 •. 
taining Ct3 and Ct4 (51°C. serum). The presence of NasEDTA in the incubation with 
C'4  decreased  hemolysis  in  the  subsequent  warm  phase,  but  Na2MgEDTA  and 
Na2CaEDTA were without effect in this step (Table XI), suggesting that the reaction 
was dependent on Mg  ++. An absolute requirement for Mg  ++ could not be concluded 
with certainty, because it was not possible to  exclude  Ct4 from subsequent steps of 
the reaction. (For unexplained reasons, R3 which had been treated with ammonia to 
inactivate C'4 could not be used as a  source of C'2 in reaction III.) C. F. HINZ,  Sit.,  M.  E.  PICKEN,  AND  I. H.  LEPOW  213 
Following  interaction with Ctl  and C~4, Ct2 was interacted by exposure of cells 
(reaction III) to R3, a reagent containing C~2 but lacking Ct3 (Table X). This reaction 
failed to occur at I°C., but was completed at 25°C., consistent with Leon's observation 
(18) that human serum reacts with sheep cells to form EACtA cells at relatively high 
temperature.  Intermediate  temperatures were  not  tested.  Na3EDTA  blocked  this 
step, but Na2MgEDTA and Na2CaEDTA did not (Table XI), indicating a require- 
ment for Mg++ during the interaction of C~2. The successful completion of this step 
was indicated by the fact that the cells treated in this manner could be subsequently 
hemolyzed by R4-51 C. serum which contains CP3 but lacks Ct2 and Ct4. If C~3 were 
present but C'2 lacking (51°C. serum) in this third step, hemolysis failed to occur in 
the subsequent reaction, further emphasizing the participation of C~2 in reaction III 
prior to  reaction with  C'3. 
Finally, after completion of the first three reactions involving C"I, C~4 and Ct2, the 
cells were hemolyzed in  the presence of C~3 by incubating  them with serum or a 
reagent containing Cr3 but lacking C'4 and C'2 (R4 heated to 51°C.)  (Table X). A 
reagent lacking Ct3  (R3)  failed to cause hemolysis.  The final reaction was routinely 
performed  at  37°C.,  and  hemolysis occurred  even  in  the  presence  of  Na~EDTA 
(Table XI), indicating that there was no divalent cation requirement in this step. 
Summary.--Hemolysis occurred only when the cells were interacted consecu- 
tively with C~I or C~I esterase at I°C., Ct4 at I°C. or higher temperature, C~2 
at a  higher temperature, and finally C~3 at higher temperature.  Ca  ++ was re- 
quired for the initial interaction with C~I esterase, and Mg  ++ was required for 
the reaction with C~2. There was no divalent cation requirement for the inter- 
action with C~3. 
DISCUSSION 
Evidence has been presented that the action  of human complement in a 
naturally  occurring  human hemolytic reaction  is  initiated  by Ctl and that the 
activity  of C~I may be related  to its  esterase  properties.  The data are these: 
A. The inactivation  of C~I in serum prevents the completion of the initial 
cold  phase of  the Donath-Landsteiner reaction,  and therefore  prevents hemoly- 
sis. 
B.  The active enzyme, Ctl esterase, derived from several sources, can be sub- 
stituted for serum as a source of complement in the cold phase. 
C.  The effect of C~I esterase can be blocked by an inhibitor of the esterase 
properties. 
D.  C~I esterase activity can be recovered from erythrocytes after they have 
been exposed to antibody and serum complement in the initial cold phase of the 
reaction. 
These observations  are  consistent  with  the  hypothesis  that  the  action  of 
human complement is initiated by activation of Ct! from its naturally occurring 
proenzyme to the active enzyme, C~I esterase (5). They are str~Mngly similar 
to  current  observations  on  the  role of complement in immune  cytotoxlcity, 214  IMMUNE  HUMAN  HEMOLYSIS.  II. 
studies in which the deleterious effects of complement on human amnion cells 
in the presence of specific antibody were initiated by C'I esterase (17, 21). They 
are also similar to the data previously  reported on the sequence of events in 
complement fixation by antigen-antibody aggregates (5). 
A variety of observations  in the present study lend support to the concept 
that the esterase properties of Cq have functional significance in the initiation 
of the hemolytic action of complement. Both the esterase preparation made by 
serum fractionation and by elution from an antigen-antibody aggregate lacked 
directly demonstrable  Cq activity, as measured by the reconstitution of hemo- 
lytic activity with R1, but were capable of completing the cold phase  of the 
Donath-Landsteiner reaction,  and therefore  had functional activity. A third 
source of Cq esterase was observed in a crude serum fraction containing anti- 
body, and this fraction by itself completed the cold phase. Further, an eluate 
made from erythrocytes after they were exposed to antibody and serum in the 
cold phase of the Donath-Landsteiner reaction contained esterase activity and 
was  capable  of substituting for serum  in a  subsequent  Donath-Landsteiner 
reaction.  Thus, the correlation  between  esterase  activity and activity in the 
cold phase  of the Donath-Landsteiner reaction was  excellent.  It was noted 
earlier, however, that the esterase preparation eluted from an antigen-antibody 
aggregate  (pneumococcal  S III--rabbit anti-S  III)  was less effective in the 
Donath-Landsteiner reaction per unit of esterase activity than the preparation 
prepared  by serum fractionation. Although direct proof is lacking, it is possible 
that the sites responsible for combination with the erythrocyte-antibody com- 
plex may have been  altered in the preparation which had been  eluted from 
another antigen-antibody complex. Becker  (20) has offered evidence that the 
sites responsible for esterase activity and combination may be different. 
Inhibition of the cold phase of the D-L reaction by a partially purified prep- 
aration of a serum inhibitor of C'I esterase provided an important line of evi- 
dence for the functional participation of C'I esterase in immune human hemoly- 
sis. It is  emphasized,  however,  that such  inhibition could be achieved  only 
with appropriately separated reactions and under selected experimental condi- 
tions. The serum inhibitor of Cq esterase effectively blocked the cold phase of 
the D-L reaction only when C~I esterase was used as the source of complement. 
The inhibitor had no effect on completion  of the cold phase  when partially 
purified Cq or whole serum were used. It is noteworthy that whole serum con- 
tains large amounts of inhibitor (15). 
Stated in another way, the inhibitor did not affect the cold phase when activa- 
tion of C'I to C'I esterase occurred at the surface of the erythrocyte-antibody 
complex. This was in agreement with previous observations  (5) that "activated 
aggregates" containing enzymatic activity could be prepared  by interacting 
antigen-antibody complexes at 0°C. for 30 minutes with Cq in whole serum 
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the activity of Cq esterase at 0°C. after the enzyme had reacted with the eryth- 
rocyte-antibody complex is unknown. It may be speculated that stereochemical 
effects may be involved. However, after successful completion of the cold phase, 
the inhibitor blocked the activity of activated erythrocytes as a  function of 
temperature, time, and concentration of inhibitor. In view of effective inhibition 
of activated erythrocytes by inhibitor at 32-37°C. (Fig. 4), the question arises 
of why serum or R1, both of which contain inhibitor, can cause hemolysis during 
the warm phase. The explanation may lie in the relative rates of the inhibitory 
and hemolytic reactions. 
Parallel studies with a variety of antigen-antibody aggregates activated in a 
similar fashion with Cq or Cq esterase indicate that the rate of interaction of 
such aggregates with C~4 is greater than the rate of inhibition by inhibitor. The 
observations on the effect of inhibitor in the D-L reaction were therefore similar 
to other studies on the role of inhibitor in complement fixation (22) and immune 
cytotoxicity (21). 
The present data do not suggest the manner of action of Cq  in the early 
stages of hemolysis. It is possible that the esterase attacks a  substrate in the 
cell,  although no substrate has been demonstrated. It is more probable that 
C~I  esterase serves only as a  point of contact or attachment for other com- 
ponents of complement. Becker has recently suggested that the latter inter- 
pretation is correct, for he has offered evidence that guinea pig Cq activity can 
be removed almost completely from sensitized sheep cells  after C~4 and Ct2 
have interacted, without interfering with the subsequent hemolytic reaction 
(23). 
The use of partially purified preparations of C~I and Ctl esterase has also 
permitted a more direct study of the sequence of action of the components of 
human complement in an all-human hemolytic reaction. Although Pillemer, 
Seifter, and Ecker offered evidence eighteen years ago that the action of guinea 
pig complement was initiated by Ctl and C~4 (2) and Mayer and his colleagues 
(3) have published a series of kinetic studies on hemolysis by guinea pig com- 
plement of sheep cells sensitized with rabbit antibody, few detailed studies have 
been done in an entirely human system. The studies of Mayer and his col- 
laborators have shown that the sequence of action of the components of guinea 
pig complement is as follows: Cq and C~4 react first in the presence of Ca  ~-, 
C~2 then reacts in a  step requiring Mg  ++, and C~3 (consisting of at least two 
components) reacts in the absence of divalent cations, following which the cells 
hemolyze spontaneously. 
The current observations indicate that in the Donath-Landsteiner hemolytic 
reaction in which cells,  antibody, and complement are of human origin, and 
which is responsible for a  specific  human disease, the sequence of events is 
similar. Thus, using Cq esterase it was shown that Cq reacts first in a step re- 
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Similar to the observations  on guinea pig complement, Ct2 then interacts in a 
step requiring Mg  ++. However, C~2 fails to interact at 0°C. as guinea pig serum 
does, but requires higher temperatures. This is similar to the observation made 
by Leon on the lysis of sheep cells by human serum (18). Finally, after reaction 
with Cq, C~4, and C~2, human Ct3 completes the Donath-Landsteiner reaction 
in the absence of divalent cations and results in hemolysis. 
Therefore,  these observations  on human complement made with sequential 
exposure of cells to variously inactivated reagents  confirm the kinetic studies 
on guinea pig complement regarding  both the sequence of action and ion re- 
quirement, and indicate further similarities  between  guinea  pig  and human 
complement whether acting in a mixed system or one of entirely human origin. 
They clarify the sequence of action in the early steps  of complement  action, 
pointing out that C~I clearly acts before C~4, in full agreement with Becker (23). 
The current data regarding the requirement for the four components of com- 
plement for the D-L reaction are similar to those for other immune hemolytic 
reactions and reactions requiring complement. They differ from those reported 
by Jordan, Dingle,  and Pillemer  (10) using guinea pig serum  as a  source  of 
complement,  which indicated that C~4 was required  for the cold phase,  and 
C'2 for the warm phase, with no requirement for C~I or C~3. Attempts to repeat 
their experiment,  utilizing  guinea  pig serum  as a  source of complement  and 
several antisera including the antibody preparation which they had used (which 
had been stored frozen for 10 years) and an identical experimental design, were 
unsuccessful. In each instance  the observations  were similar to those made in 
the present studies  with human serum  and indicated a  requirement for  C~I 
in the cold phase and for the other three components in the warm.  There was 
agreement that serum heated to 56°C., lacking Ctl but containing  C"4, failed 
to complete the cold phase. Heated serum would have been expected to have 
been active in the cold phase if CP4 were the sole cold phase requirement as they 
proposed  (10). The discrepancies between the two studies remain unexplained 
despite numerous discussions with Drs.  Jordan and Dingle, and their assistance 
in designing experiments and in supplying antibody. 
It is concluded that in the Donath-Landsteiner reaction,  an immune hemo- 
lytic reaction responsible for a specific human disease, paroxysmal cold hemo- 
globinuria, hemolysis is mediated by specific antibody, all of the components of 
complement and Ca  -H- and Mg  ++, and that an early event in the mechanism of 
hemolysis is activation of Ctl to Ctl esterase. This reaction provides a useful 
model for studying the mechanism  of action of complement  and of the  en- 
zymatic nature of immune reactions in human disease. 
SUMMARY 
1.  The inactivation of Cq  blocks the completion  of the cold phase  of the 
Donath-Landsteiner reaction; inactivation of the other components of comple- 
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2.  C'2,  C~3, and C'4 are required for the completion of the hemolytic reac- 
tion. C~4 reacts in either the cold or warm phase, but  C~2 and C~3 must react 
in the warm phase. 
3.  Partially purified Cq or C~1 esterase can be substituted for whole serum 
in the  cold phase,  although neither reagent  contains  any of the other com- 
ponents of complement 
4.  Partially purified serum inhibitor of Cq  esterase blocks the effect of C~1 
esterase in the cold phase, and reverses the effect of complement, Ctl  or Ctl 
esterase when incubated with "activated" cells after the cold phase. 
5.  C~1  esterase activity can be eluted from "activated" erythrocytes with 
Na3EDTA. 
6.  The components of human complement in this human hemolytic reaction 
act in the order Cq, C~4, Cr2, C~3. Ca  ++ is required for the reaction with Cq, 
and Mg  ++ is required for the reaction with C~2. 
7.  Accordingly, a functional role of C~1 esterase in a human disease state is 
demonstrated, anda humanmodelis established for the study of the mechanism 
of action of complement. 
Thanks are owed to Dr. Jack Pensky for providing partially purified esterase inhibitor; 
to Mr. Goldwyn  Hughes for performing  esterase assays; and to Drs. R. C. Griggs and G. O. 
Clifford for supplying Donath-Landsteiner antiserum. 
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